nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoprofen—PTGS2—Etoposide—sarcoma	0.0656	0.429	CbGbCtD
Ketoprofen—PTGS1—Etoposide—sarcoma	0.0554	0.362	CbGbCtD
Ketoprofen—CYP2C8—Etoposide—sarcoma	0.0319	0.209	CbGbCtD
Ketoprofen—CXCR1—bone marrow—sarcoma	0.0091	0.0658	CbGeAlD
Ketoprofen—PTGS2—periosteum—sarcoma	0.00737	0.0534	CbGeAlD
Ketoprofen—PTGS2—leg—sarcoma	0.00588	0.0425	CbGeAlD
Ketoprofen—CXCL8—myometrium—sarcoma	0.00586	0.0424	CbGeAlD
Ketoprofen—CXCR1—lymph node—sarcoma	0.00564	0.0408	CbGeAlD
Ketoprofen—PTGS2—hindlimb—sarcoma	0.00525	0.038	CbGeAlD
Ketoprofen—PTGS2—cartilage tissue—sarcoma	0.00517	0.0374	CbGeAlD
Ketoprofen—PTGS2—appendage—sarcoma	0.0045	0.0326	CbGeAlD
Ketoprofen—CXCL8—smooth muscle tissue—sarcoma	0.00443	0.0321	CbGeAlD
Ketoprofen—ALB—mammary gland—sarcoma	0.00402	0.0291	CbGeAlD
Ketoprofen—CXCL8—bone marrow—sarcoma	0.00323	0.0234	CbGeAlD
Ketoprofen—PTGS1—endothelium—sarcoma	0.00284	0.0206	CbGeAlD
Ketoprofen—CYP2C8—mammary gland—sarcoma	0.00283	0.0205	CbGeAlD
Ketoprofen—CXCL8—testis—sarcoma	0.00276	0.02	CbGeAlD
Ketoprofen—PTGS2—endothelium—sarcoma	0.00272	0.0197	CbGeAlD
Ketoprofen—CXCL8—liver—sarcoma	0.00261	0.0189	CbGeAlD
Ketoprofen—CYP2C9—mammary gland—sarcoma	0.00251	0.0182	CbGeAlD
Ketoprofen—SLCO1A2—hematopoietic system—sarcoma	0.00246	0.0178	CbGeAlD
Ketoprofen—ABCC4—hematopoietic system—sarcoma	0.00237	0.0172	CbGeAlD
Ketoprofen—SLC22A8—hematopoietic system—sarcoma	0.00235	0.017	CbGeAlD
Ketoprofen—SLC22A7—testis—sarcoma	0.00223	0.0161	CbGeAlD
Ketoprofen—SLC22A11—liver—sarcoma	0.00216	0.0156	CbGeAlD
Ketoprofen—SLC22A7—liver—sarcoma	0.00211	0.0153	CbGeAlD
Ketoprofen—CXCL8—lymph node—sarcoma	0.002	0.0145	CbGeAlD
Ketoprofen—ABCC4—uterus—sarcoma	0.00179	0.013	CbGeAlD
Ketoprofen—CYP2C8—hematopoietic system—sarcoma	0.00172	0.0125	CbGeAlD
Ketoprofen—ABCC4—tendon—sarcoma	0.00157	0.0114	CbGeAlD
Ketoprofen—PTGS2—myometrium—sarcoma	0.00155	0.0113	CbGeAlD
Ketoprofen—CYP2C9—hematopoietic system—sarcoma	0.00153	0.0111	CbGeAlD
Ketoprofen—ABCC4—bone marrow—sarcoma	0.00152	0.011	CbGeAlD
Ketoprofen—PTGS2—embryo—sarcoma	0.0015	0.0108	CbGeAlD
Ketoprofen—PTGS1—seminal vesicle—sarcoma	0.00147	0.0106	CbGeAlD
Ketoprofen—PTGS2—seminal vesicle—sarcoma	0.0014	0.0102	CbGeAlD
Ketoprofen—PTGS1—hematopoietic system—sarcoma	0.0014	0.0101	CbGeAlD
Ketoprofen—SLCO1A2—testis—sarcoma	0.00135	0.00978	CbGeAlD
Ketoprofen—PTGS1—connective tissue—sarcoma	0.00134	0.00973	CbGeAlD
Ketoprofen—ALB—testis—sarcoma	0.00134	0.00972	CbGeAlD
Ketoprofen—PTGS2—hematopoietic system—sarcoma	0.00133	0.00966	CbGeAlD
Ketoprofen—ABCC4—testis—sarcoma	0.0013	0.00941	CbGeAlD
Ketoprofen—PTGS2—connective tissue—sarcoma	0.00129	0.0093	CbGeAlD
Ketoprofen—SLCO1A2—liver—sarcoma	0.00128	0.00924	CbGeAlD
Ketoprofen—ALB—liver—sarcoma	0.00127	0.00919	CbGeAlD
Ketoprofen—PTGS1—smooth muscle tissue—sarcoma	0.00123	0.0089	CbGeAlD
Ketoprofen—ABCC4—liver—sarcoma	0.00123	0.00889	CbGeAlD
Ketoprofen—PTGS1—skin of body—sarcoma	0.00121	0.00879	CbGeAlD
Ketoprofen—PTGS2—smooth muscle tissue—sarcoma	0.00118	0.00851	CbGeAlD
Ketoprofen—PTGS2—skin of body—sarcoma	0.00116	0.0084	CbGeAlD
Ketoprofen—PTGS1—cardiac atrium—sarcoma	0.00106	0.00767	CbGeAlD
Ketoprofen—PTGS1—uterus—sarcoma	0.00105	0.00763	CbGeAlD
Ketoprofen—PTGS2—uterus—sarcoma	0.00101	0.0073	CbGeAlD
Ketoprofen—ALB—lymph node—sarcoma	0.000973	0.00705	CbGeAlD
Ketoprofen—CYP2C8—testis—sarcoma	0.000944	0.00683	CbGeAlD
Ketoprofen—ABCC4—lymph node—sarcoma	0.000942	0.00682	CbGeAlD
Ketoprofen—PTGS2—lymphoid tissue—sarcoma	0.00094	0.0068	CbGeAlD
Ketoprofen—PTGS1—tendon—sarcoma	0.000924	0.00669	CbGeAlD
Ketoprofen—CYP2C8—liver—sarcoma	0.000892	0.00646	CbGeAlD
Ketoprofen—PTGS2—tendon—sarcoma	0.000883	0.00639	CbGeAlD
Ketoprofen—PTGS2—bone marrow—sarcoma	0.000856	0.00619	CbGeAlD
Ketoprofen—Paraesthesia—Vincristine—sarcoma	0.000847	0.0015	CcSEcCtD
Ketoprofen—Urticaria—Thiotepa—sarcoma	0.000845	0.0015	CcSEcCtD
Ketoprofen—Malaise—Etoposide—sarcoma	0.000844	0.00149	CcSEcCtD
Ketoprofen—Dermatitis bullous—Doxorubicin—sarcoma	0.000843	0.00149	CcSEcCtD
Ketoprofen—Face oedema—Epirubicin—sarcoma	0.000841	0.00149	CcSEcCtD
Ketoprofen—Vertigo—Etoposide—sarcoma	0.000841	0.00149	CcSEcCtD
Ketoprofen—Abdominal pain—Thiotepa—sarcoma	0.000841	0.00149	CcSEcCtD
Ketoprofen—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000837	0.00148	CcSEcCtD
Ketoprofen—Purpura—Doxorubicin—sarcoma	0.000836	0.00148	CcSEcCtD
Ketoprofen—Abdominal pain—Dactinomycin—sarcoma	0.000834	0.00148	CcSEcCtD
Ketoprofen—Cardiac failure—Doxorubicin—sarcoma	0.000826	0.00146	CcSEcCtD
Ketoprofen—Paraesthesia—Mitoxantrone—sarcoma	0.000825	0.00146	CcSEcCtD
Ketoprofen—Decreased appetite—Vincristine—sarcoma	0.00082	0.00145	CcSEcCtD
Ketoprofen—Dyspnoea—Mitoxantrone—sarcoma	0.000819	0.00145	CcSEcCtD
Ketoprofen—Somnolence—Mitoxantrone—sarcoma	0.000816	0.00145	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Vincristine—sarcoma	0.000814	0.00144	CcSEcCtD
Ketoprofen—Fatigue—Vincristine—sarcoma	0.000813	0.00144	CcSEcCtD
Ketoprofen—Convulsion—Etoposide—sarcoma	0.000811	0.00144	CcSEcCtD
Ketoprofen—Hyponatraemia—Doxorubicin—sarcoma	0.000809	0.00143	CcSEcCtD
Ketoprofen—Dyspepsia—Mitoxantrone—sarcoma	0.000808	0.00143	CcSEcCtD
Ketoprofen—Hypertension—Etoposide—sarcoma	0.000808	0.00143	CcSEcCtD
Ketoprofen—Constipation—Vincristine—sarcoma	0.000806	0.00143	CcSEcCtD
Ketoprofen—Gastrointestinal haemorrhage—Doxorubicin—sarcoma	0.000806	0.00143	CcSEcCtD
Ketoprofen—Decreased appetite—Mitoxantrone—sarcoma	0.000798	0.00141	CcSEcCtD
Ketoprofen—Abdominal pain upper—Epirubicin—sarcoma	0.000796	0.00141	CcSEcCtD
Ketoprofen—Migraine—Doxorubicin—sarcoma	0.000793	0.00141	CcSEcCtD
Ketoprofen—CYP2C9—liver—sarcoma	0.000793	0.00574	CbGeAlD
Ketoprofen—Fatigue—Mitoxantrone—sarcoma	0.000792	0.0014	CcSEcCtD
Ketoprofen—Discomfort—Etoposide—sarcoma	0.000787	0.00139	CcSEcCtD
Ketoprofen—Constipation—Mitoxantrone—sarcoma	0.000785	0.00139	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000784	0.00139	CcSEcCtD
Ketoprofen—Hypersensitivity—Thiotepa—sarcoma	0.000783	0.00139	CcSEcCtD
Ketoprofen—Face oedema—Doxorubicin—sarcoma	0.000778	0.00138	CcSEcCtD
Ketoprofen—Hypersensitivity—Dactinomycin—sarcoma	0.000777	0.00138	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Vincristine—sarcoma	0.000771	0.00137	CcSEcCtD
Ketoprofen—Gastritis—Epirubicin—sarcoma	0.000771	0.00137	CcSEcCtD
Ketoprofen—Confusional state—Etoposide—sarcoma	0.00077	0.00136	CcSEcCtD
Ketoprofen—PTGS1—testis—sarcoma	0.000765	0.00554	CbGeAlD
Ketoprofen—Anaphylactic shock—Etoposide—sarcoma	0.000764	0.00135	CcSEcCtD
Ketoprofen—Asthenia—Thiotepa—sarcoma	0.000763	0.00135	CcSEcCtD
Ketoprofen—Infection—Etoposide—sarcoma	0.000759	0.00134	CcSEcCtD
Ketoprofen—Asthenia—Dactinomycin—sarcoma	0.000757	0.00134	CcSEcCtD
Ketoprofen—Feeling abnormal—Mitoxantrone—sarcoma	0.000757	0.00134	CcSEcCtD
Ketoprofen—Asthma—Epirubicin—sarcoma	0.000753	0.00133	CcSEcCtD
Ketoprofen—Pruritus—Thiotepa—sarcoma	0.000752	0.00133	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000751	0.00133	CcSEcCtD
Ketoprofen—Thrombocytopenia—Etoposide—sarcoma	0.000748	0.00132	CcSEcCtD
Ketoprofen—Tachycardia—Etoposide—sarcoma	0.000745	0.00132	CcSEcCtD
Ketoprofen—Abdominal pain—Vincristine—sarcoma	0.000745	0.00132	CcSEcCtD
Ketoprofen—Hyperhidrosis—Etoposide—sarcoma	0.000738	0.00131	CcSEcCtD
Ketoprofen—Pancreatitis—Epirubicin—sarcoma	0.000738	0.00131	CcSEcCtD
Ketoprofen—Abdominal pain upper—Doxorubicin—sarcoma	0.000736	0.0013	CcSEcCtD
Ketoprofen—Urticaria—Mitoxantrone—sarcoma	0.000729	0.00129	CcSEcCtD
Ketoprofen—Anorexia—Etoposide—sarcoma	0.000728	0.00129	CcSEcCtD
Ketoprofen—Diarrhoea—Thiotepa—sarcoma	0.000728	0.00129	CcSEcCtD
Ketoprofen—Abdominal pain—Mitoxantrone—sarcoma	0.000726	0.00129	CcSEcCtD
Ketoprofen—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000726	0.00129	CcSEcCtD
Ketoprofen—Diarrhoea—Dactinomycin—sarcoma	0.000722	0.00128	CcSEcCtD
Ketoprofen—Gastritis—Doxorubicin—sarcoma	0.000713	0.00126	CcSEcCtD
Ketoprofen—Dizziness—Thiotepa—sarcoma	0.000703	0.00125	CcSEcCtD
Ketoprofen—Asthma—Doxorubicin—sarcoma	0.000697	0.00123	CcSEcCtD
Ketoprofen—Hypersensitivity—Vincristine—sarcoma	0.000695	0.00123	CcSEcCtD
Ketoprofen—PTGS2—liver—sarcoma	0.000692	0.00501	CbGeAlD
Ketoprofen—Photosensitivity reaction—Epirubicin—sarcoma	0.000687	0.00122	CcSEcCtD
Ketoprofen—Paraesthesia—Etoposide—sarcoma	0.000686	0.00121	CcSEcCtD
Ketoprofen—Weight increased—Epirubicin—sarcoma	0.000685	0.00121	CcSEcCtD
Ketoprofen—Pancreatitis—Doxorubicin—sarcoma	0.000683	0.00121	CcSEcCtD
Ketoprofen—Weight decreased—Epirubicin—sarcoma	0.000681	0.00121	CcSEcCtD
Ketoprofen—Dyspnoea—Etoposide—sarcoma	0.000681	0.00121	CcSEcCtD
Ketoprofen—Somnolence—Etoposide—sarcoma	0.000679	0.0012	CcSEcCtD
Ketoprofen—SLC22A7—Fluoropyrimidine Activity—TP53—sarcoma	0.000679	0.0047	CbGpPWpGaD
Ketoprofen—CXCL8—Peptide ligand-binding receptors—CXCR4—sarcoma	0.000677	0.00469	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Mitoxantrone—sarcoma	0.000677	0.0012	CcSEcCtD
Ketoprofen—Asthenia—Vincristine—sarcoma	0.000676	0.0012	CcSEcCtD
Ketoprofen—Vomiting—Thiotepa—sarcoma	0.000676	0.0012	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—sarcoma	0.000674	0.00467	CbGpPWpGaD
Ketoprofen—Drowsiness—Epirubicin—sarcoma	0.000671	0.00119	CcSEcCtD
Ketoprofen—Vomiting—Dactinomycin—sarcoma	0.000671	0.00119	CcSEcCtD
Ketoprofen—Rash—Thiotepa—sarcoma	0.00067	0.00119	CcSEcCtD
Ketoprofen—Dermatitis—Thiotepa—sarcoma	0.00067	0.00119	CcSEcCtD
Ketoprofen—PTGS2—Selenium Micronutrient Network—HBA1—sarcoma	0.000669	0.00463	CbGpPWpGaD
Ketoprofen—Headache—Thiotepa—sarcoma	0.000666	0.00118	CcSEcCtD
Ketoprofen—CXCL8—ATF-2 transcription factor network—CCND1—sarcoma	0.000666	0.00461	CbGpPWpGaD
Ketoprofen—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.000666	0.00118	CcSEcCtD
Ketoprofen—Rash—Dactinomycin—sarcoma	0.000665	0.00118	CcSEcCtD
Ketoprofen—CXCL8—ATF-2 transcription factor network—JUN—sarcoma	0.000665	0.0046	CbGpPWpGaD
Ketoprofen—Decreased appetite—Etoposide—sarcoma	0.000664	0.00118	CcSEcCtD
Ketoprofen—Renal failure—Epirubicin—sarcoma	0.00066	0.00117	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Etoposide—sarcoma	0.000659	0.00117	CcSEcCtD
Ketoprofen—Asthenia—Mitoxantrone—sarcoma	0.000659	0.00117	CcSEcCtD
Ketoprofen—Fatigue—Etoposide—sarcoma	0.000658	0.00117	CcSEcCtD
Ketoprofen—Jaundice—Epirubicin—sarcoma	0.000654	0.00116	CcSEcCtD
Ketoprofen—Stomatitis—Epirubicin—sarcoma	0.000654	0.00116	CcSEcCtD
Ketoprofen—Constipation—Etoposide—sarcoma	0.000653	0.00116	CcSEcCtD
Ketoprofen—Conjunctivitis—Epirubicin—sarcoma	0.000653	0.00116	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—CREB1—sarcoma	0.000648	0.00449	CbGpPWpGaD
Ketoprofen—Diarrhoea—Vincristine—sarcoma	0.000645	0.00114	CcSEcCtD
Ketoprofen—Sweating—Epirubicin—sarcoma	0.000644	0.00114	CcSEcCtD
Ketoprofen—CXCL8—TSLP Signaling Pathway—MYC—sarcoma	0.000641	0.00444	CbGpPWpGaD
Ketoprofen—Haematuria—Epirubicin—sarcoma	0.00064	0.00113	CcSEcCtD
Ketoprofen—Photosensitivity reaction—Doxorubicin—sarcoma	0.000636	0.00113	CcSEcCtD
Ketoprofen—ALB—Platelet degranulation—VEGFC—sarcoma	0.000635	0.0044	CbGpPWpGaD
Ketoprofen—Weight increased—Doxorubicin—sarcoma	0.000634	0.00112	CcSEcCtD
Ketoprofen—Epistaxis—Epirubicin—sarcoma	0.000633	0.00112	CcSEcCtD
Ketoprofen—Nausea—Thiotepa—sarcoma	0.000632	0.00112	CcSEcCtD
Ketoprofen—Weight decreased—Doxorubicin—sarcoma	0.00063	0.00112	CcSEcCtD
Ketoprofen—PTGS2—S1P1 pathway—VEGFA—sarcoma	0.00063	0.00436	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Etoposide—sarcoma	0.000629	0.00111	CcSEcCtD
Ketoprofen—Diarrhoea—Mitoxantrone—sarcoma	0.000628	0.00111	CcSEcCtD
Ketoprofen—Nausea—Dactinomycin—sarcoma	0.000627	0.00111	CcSEcCtD
Ketoprofen—Agranulocytosis—Epirubicin—sarcoma	0.000626	0.00111	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Etoposide—sarcoma	0.000625	0.00111	CcSEcCtD
Ketoprofen—Dizziness—Vincristine—sarcoma	0.000623	0.0011	CcSEcCtD
Ketoprofen—CXCL8—Syndecan-2-mediated signaling events—HRAS—sarcoma	0.000623	0.00431	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—JUN—sarcoma	0.000623	0.00431	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000622	0.00431	CbGpPWpGaD
Ketoprofen—Drowsiness—Doxorubicin—sarcoma	0.000621	0.0011	CcSEcCtD
Ketoprofen—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.000616	0.00109	CcSEcCtD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.000615	0.00426	CbGpPWpGaD
Ketoprofen—Renal failure—Doxorubicin—sarcoma	0.000611	0.00108	CcSEcCtD
Ketoprofen—Urticaria—Etoposide—sarcoma	0.000607	0.00107	CcSEcCtD
Ketoprofen—Stomatitis—Doxorubicin—sarcoma	0.000605	0.00107	CcSEcCtD
Ketoprofen—Jaundice—Doxorubicin—sarcoma	0.000605	0.00107	CcSEcCtD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000605	0.00419	CbGpPWpGaD
Ketoprofen—Rhinitis—Epirubicin—sarcoma	0.000604	0.00107	CcSEcCtD
Ketoprofen—Abdominal pain—Etoposide—sarcoma	0.000604	0.00107	CcSEcCtD
Ketoprofen—Conjunctivitis—Doxorubicin—sarcoma	0.000604	0.00107	CcSEcCtD
Ketoprofen—CYP2C9—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000603	0.00418	CbGpPWpGaD
Ketoprofen—Hepatitis—Epirubicin—sarcoma	0.000603	0.00107	CcSEcCtD
Ketoprofen—Vomiting—Vincristine—sarcoma	0.000599	0.00106	CcSEcCtD
Ketoprofen—Pharyngitis—Epirubicin—sarcoma	0.000598	0.00106	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—IL2—sarcoma	0.000596	0.00413	CbGpPWpGaD
Ketoprofen—Sweating—Doxorubicin—sarcoma	0.000595	0.00105	CcSEcCtD
Ketoprofen—Rash—Vincristine—sarcoma	0.000594	0.00105	CcSEcCtD
Ketoprofen—Dermatitis—Vincristine—sarcoma	0.000594	0.00105	CcSEcCtD
Ketoprofen—Haematuria—Doxorubicin—sarcoma	0.000592	0.00105	CcSEcCtD
Ketoprofen—Headache—Vincristine—sarcoma	0.000591	0.00105	CcSEcCtD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—MDM2—sarcoma	0.000588	0.00407	CbGpPWpGaD
Ketoprofen—Epistaxis—Doxorubicin—sarcoma	0.000586	0.00104	CcSEcCtD
Ketoprofen—Vomiting—Mitoxantrone—sarcoma	0.000584	0.00103	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—CCND1—sarcoma	0.000581	0.00402	CbGpPWpGaD
Ketoprofen—Visual impairment—Epirubicin—sarcoma	0.000581	0.00103	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—JUN—sarcoma	0.00058	0.00401	CbGpPWpGaD
Ketoprofen—Agranulocytosis—Doxorubicin—sarcoma	0.00058	0.00103	CcSEcCtD
Ketoprofen—Rash—Mitoxantrone—sarcoma	0.000579	0.00103	CcSEcCtD
Ketoprofen—Dermatitis—Mitoxantrone—sarcoma	0.000578	0.00102	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—CTNNB1—sarcoma	0.000575	0.00398	CbGpPWpGaD
Ketoprofen—Headache—Mitoxantrone—sarcoma	0.000575	0.00102	CcSEcCtD
Ketoprofen—CXCL8—G alpha (i) signalling events—CXCR4—sarcoma	0.000571	0.00396	CbGpPWpGaD
Ketoprofen—Erythema multiforme—Epirubicin—sarcoma	0.00057	0.00101	CcSEcCtD
Ketoprofen—Hypersensitivity—Etoposide—sarcoma	0.000563	0.000997	CcSEcCtD
Ketoprofen—Tinnitus—Epirubicin—sarcoma	0.000562	0.000995	CcSEcCtD
Ketoprofen—Nausea—Vincristine—sarcoma	0.00056	0.000992	CcSEcCtD
Ketoprofen—Flushing—Epirubicin—sarcoma	0.000559	0.000991	CcSEcCtD
Ketoprofen—Rhinitis—Doxorubicin—sarcoma	0.000559	0.00099	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—SRC—sarcoma	0.000559	0.00387	CbGpPWpGaD
Ketoprofen—Hepatitis—Doxorubicin—sarcoma	0.000558	0.000988	CcSEcCtD
Ketoprofen—PTGS1—lymph node—sarcoma	0.000555	0.00401	CbGeAlD
Ketoprofen—Pharyngitis—Doxorubicin—sarcoma	0.000553	0.00098	CcSEcCtD
Ketoprofen—Asthenia—Etoposide—sarcoma	0.000548	0.000971	CcSEcCtD
Ketoprofen—ABCC4—Fluoropyrimidine Activity—TP53—sarcoma	0.000547	0.00379	CbGpPWpGaD
Ketoprofen—Nausea—Mitoxantrone—sarcoma	0.000545	0.000966	CcSEcCtD
Ketoprofen—ALB—Selenium Micronutrient Network—HBA1—sarcoma	0.000541	0.00375	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—IL2—sarcoma	0.000541	0.00375	CbGpPWpGaD
Ketoprofen—Chills—Epirubicin—sarcoma	0.000541	0.000958	CcSEcCtD
Ketoprofen—Pruritus—Etoposide—sarcoma	0.00054	0.000957	CcSEcCtD
Ketoprofen—Arrhythmia—Epirubicin—sarcoma	0.000538	0.000953	CcSEcCtD
Ketoprofen—Visual impairment—Doxorubicin—sarcoma	0.000537	0.000952	CcSEcCtD
Ketoprofen—Alopecia—Epirubicin—sarcoma	0.000533	0.000943	CcSEcCtD
Ketoprofen—PTGS2—lymph node—sarcoma	0.00053	0.00384	CbGeAlD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—sarcoma	0.000528	0.00366	CbGpPWpGaD
Ketoprofen—Erythema multiforme—Doxorubicin—sarcoma	0.000527	0.000934	CcSEcCtD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—IL2—sarcoma	0.000525	0.00364	CbGpPWpGaD
Ketoprofen—Erythema—Epirubicin—sarcoma	0.000525	0.000929	CcSEcCtD
Ketoprofen—Diarrhoea—Etoposide—sarcoma	0.000523	0.000926	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—sarcoma	0.000522	0.00362	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—sarcoma	0.000521	0.00361	CbGpPWpGaD
Ketoprofen—Tinnitus—Doxorubicin—sarcoma	0.00052	0.000921	CcSEcCtD
Ketoprofen—Flushing—Doxorubicin—sarcoma	0.000517	0.000917	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—sarcoma	0.000517	0.00358	CbGpPWpGaD
Ketoprofen—Flatulence—Epirubicin—sarcoma	0.000517	0.000916	CcSEcCtD
Ketoprofen—Tension—Epirubicin—sarcoma	0.000515	0.000912	CcSEcCtD
Ketoprofen—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—sarcoma	0.000514	0.00356	CbGpPWpGaD
Ketoprofen—Dysgeusia—Epirubicin—sarcoma	0.000514	0.00091	CcSEcCtD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—JUN—sarcoma	0.000511	0.00354	CbGpPWpGaD
Ketoprofen—Nervousness—Epirubicin—sarcoma	0.00051	0.000902	CcSEcCtD
Ketoprofen—Dizziness—Etoposide—sarcoma	0.000505	0.000895	CcSEcCtD
Ketoprofen—Chills—Doxorubicin—sarcoma	0.0005	0.000886	CcSEcCtD
Ketoprofen—Arrhythmia—Doxorubicin—sarcoma	0.000498	0.000882	CcSEcCtD
Ketoprofen—Alopecia—Doxorubicin—sarcoma	0.000493	0.000873	CcSEcCtD
Ketoprofen—CXCL8—LPA receptor mediated events—EGFR—sarcoma	0.00049	0.00339	CbGpPWpGaD
Ketoprofen—CXCL8—IL-3 Signaling Pathway—HRAS—sarcoma	0.000487	0.00337	CbGpPWpGaD
Ketoprofen—Ill-defined disorder—Epirubicin—sarcoma	0.000487	0.000862	CcSEcCtD
Ketoprofen—Vomiting—Etoposide—sarcoma	0.000486	0.00086	CcSEcCtD
Ketoprofen—Erythema—Doxorubicin—sarcoma	0.000485	0.00086	CcSEcCtD
Ketoprofen—Anaemia—Epirubicin—sarcoma	0.000485	0.000859	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—MDM2—sarcoma	0.000482	0.00334	CbGpPWpGaD
Ketoprofen—Rash—Etoposide—sarcoma	0.000482	0.000853	CcSEcCtD
Ketoprofen—Dermatitis—Etoposide—sarcoma	0.000481	0.000852	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—IL2—sarcoma	0.000479	0.00332	CbGpPWpGaD
Ketoprofen—Headache—Etoposide—sarcoma	0.000478	0.000847	CcSEcCtD
Ketoprofen—Flatulence—Doxorubicin—sarcoma	0.000478	0.000847	CcSEcCtD
Ketoprofen—Tension—Doxorubicin—sarcoma	0.000476	0.000844	CcSEcCtD
Ketoprofen—Dysgeusia—Doxorubicin—sarcoma	0.000475	0.000842	CcSEcCtD
Ketoprofen—Malaise—Epirubicin—sarcoma	0.000473	0.000838	CcSEcCtD
Ketoprofen—Nervousness—Doxorubicin—sarcoma	0.000471	0.000835	CcSEcCtD
Ketoprofen—Vertigo—Epirubicin—sarcoma	0.000471	0.000835	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—MYC—sarcoma	0.000466	0.00323	CbGpPWpGaD
Ketoprofen—Palpitations—Epirubicin—sarcoma	0.000464	0.000821	CcSEcCtD
Ketoprofen—CXCL8—Corticotropin-releasing hormone—CTNNB1—sarcoma	0.000462	0.0032	CbGpPWpGaD
Ketoprofen—CXCL8—Allograft Rejection—VEGFA—sarcoma	0.00046	0.00318	CbGpPWpGaD
Ketoprofen—Convulsion—Epirubicin—sarcoma	0.000455	0.000805	CcSEcCtD
Ketoprofen—CXCL8—Class A/1 (Rhodopsin-like receptors)—CXCR4—sarcoma	0.000454	0.00314	CbGpPWpGaD
Ketoprofen—Nausea—Etoposide—sarcoma	0.000454	0.000804	CcSEcCtD
Ketoprofen—Hypertension—Epirubicin—sarcoma	0.000453	0.000802	CcSEcCtD
Ketoprofen—Ill-defined disorder—Doxorubicin—sarcoma	0.00045	0.000798	CcSEcCtD
Ketoprofen—Anaemia—Doxorubicin—sarcoma	0.000449	0.000795	CcSEcCtD
Ketoprofen—Myalgia—Epirubicin—sarcoma	0.000447	0.000791	CcSEcCtD
Ketoprofen—Anxiety—Epirubicin—sarcoma	0.000445	0.000788	CcSEcCtD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.000442	0.00306	CbGpPWpGaD
Ketoprofen—Discomfort—Epirubicin—sarcoma	0.000441	0.000782	CcSEcCtD
Ketoprofen—Malaise—Doxorubicin—sarcoma	0.000438	0.000775	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—TEK—sarcoma	0.000437	0.00303	CbGpPWpGaD
Ketoprofen—Dry mouth—Epirubicin—sarcoma	0.000437	0.000774	CcSEcCtD
Ketoprofen—Vertigo—Doxorubicin—sarcoma	0.000436	0.000772	CcSEcCtD
Ketoprofen—CXCR1—GPCR downstream signaling—CXCR4—sarcoma	0.000433	0.003	CbGpPWpGaD
Ketoprofen—Confusional state—Epirubicin—sarcoma	0.000432	0.000765	CcSEcCtD
Ketoprofen—CXCL8—Toll-like Receptor Signaling Pathway—JUN—sarcoma	0.000429	0.00297	CbGpPWpGaD
Ketoprofen—Palpitations—Doxorubicin—sarcoma	0.000429	0.00076	CcSEcCtD
Ketoprofen—Anaphylactic shock—Epirubicin—sarcoma	0.000428	0.000758	CcSEcCtD
Ketoprofen—Oedema—Epirubicin—sarcoma	0.000428	0.000758	CcSEcCtD
Ketoprofen—Infection—Epirubicin—sarcoma	0.000425	0.000753	CcSEcCtD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000425	0.00294	CbGpPWpGaD
Ketoprofen—Shock—Epirubicin—sarcoma	0.000421	0.000746	CcSEcCtD
Ketoprofen—Convulsion—Doxorubicin—sarcoma	0.000421	0.000745	CcSEcCtD
Ketoprofen—Thrombocytopenia—Epirubicin—sarcoma	0.000419	0.000742	CcSEcCtD
Ketoprofen—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—JUN—sarcoma	0.000419	0.0029	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—JUN—sarcoma	0.000419	0.0029	CbGpPWpGaD
Ketoprofen—Hypertension—Doxorubicin—sarcoma	0.000419	0.000742	CcSEcCtD
Ketoprofen—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—sarcoma	0.000419	0.0029	CbGpPWpGaD
Ketoprofen—Tachycardia—Epirubicin—sarcoma	0.000418	0.00074	CcSEcCtD
Ketoprofen—ALB—FOXA2 and FOXA3 transcription factor networks—CREB1—sarcoma	0.000414	0.00287	CbGpPWpGaD
Ketoprofen—Hyperhidrosis—Epirubicin—sarcoma	0.000414	0.000733	CcSEcCtD
Ketoprofen—Myalgia—Doxorubicin—sarcoma	0.000413	0.000732	CcSEcCtD
Ketoprofen—Anxiety—Doxorubicin—sarcoma	0.000412	0.000729	CcSEcCtD
Ketoprofen—Discomfort—Doxorubicin—sarcoma	0.000408	0.000723	CcSEcCtD
Ketoprofen—Anorexia—Epirubicin—sarcoma	0.000408	0.000723	CcSEcCtD
Ketoprofen—Dry mouth—Doxorubicin—sarcoma	0.000404	0.000716	CcSEcCtD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000404	0.0028	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—ANGPT2—sarcoma	0.0004	0.00277	CbGpPWpGaD
Ketoprofen—Confusional state—Doxorubicin—sarcoma	0.000399	0.000707	CcSEcCtD
Ketoprofen—Anaphylactic shock—Doxorubicin—sarcoma	0.000396	0.000702	CcSEcCtD
Ketoprofen—Oedema—Doxorubicin—sarcoma	0.000396	0.000702	CcSEcCtD
Ketoprofen—Infection—Doxorubicin—sarcoma	0.000394	0.000697	CcSEcCtD
Ketoprofen—CXCR1—Signaling by GPCR—CXCR4—sarcoma	0.000393	0.00272	CbGpPWpGaD
Ketoprofen—CXCL8—LPA receptor mediated events—HRAS—sarcoma	0.000393	0.00272	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—IL2—sarcoma	0.000392	0.00272	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00039	0.000691	CcSEcCtD
Ketoprofen—Shock—Doxorubicin—sarcoma	0.00039	0.00069	CcSEcCtD
Ketoprofen—Thrombocytopenia—Doxorubicin—sarcoma	0.000388	0.000687	CcSEcCtD
Ketoprofen—Insomnia—Epirubicin—sarcoma	0.000387	0.000686	CcSEcCtD
Ketoprofen—Tachycardia—Doxorubicin—sarcoma	0.000387	0.000685	CcSEcCtD
Ketoprofen—Paraesthesia—Epirubicin—sarcoma	0.000384	0.000681	CcSEcCtD
Ketoprofen—Hyperhidrosis—Doxorubicin—sarcoma	0.000383	0.000678	CcSEcCtD
Ketoprofen—CXCL8—AP-1 transcription factor network—TP53—sarcoma	0.000383	0.00265	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—CCND1—sarcoma	0.000383	0.00265	CbGpPWpGaD
Ketoprofen—Dyspnoea—Epirubicin—sarcoma	0.000382	0.000676	CcSEcCtD
Ketoprofen—Somnolence—Epirubicin—sarcoma	0.000381	0.000674	CcSEcCtD
Ketoprofen—Anorexia—Doxorubicin—sarcoma	0.000378	0.000669	CcSEcCtD
Ketoprofen—Dyspepsia—Epirubicin—sarcoma	0.000377	0.000667	CcSEcCtD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—SRC—sarcoma	0.000376	0.0026	CbGpPWpGaD
Ketoprofen—Decreased appetite—Epirubicin—sarcoma	0.000372	0.000659	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Epirubicin—sarcoma	0.00037	0.000655	CcSEcCtD
Ketoprofen—Fatigue—Epirubicin—sarcoma	0.000369	0.000654	CcSEcCtD
Ketoprofen—Constipation—Epirubicin—sarcoma	0.000366	0.000648	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—TLE1—sarcoma	0.000365	0.00253	CbGpPWpGaD
Ketoprofen—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000361	0.000639	CcSEcCtD
Ketoprofen—Insomnia—Doxorubicin—sarcoma	0.000358	0.000635	CcSEcCtD
Ketoprofen—ABCC4—Platelet degranulation—VEGFA—sarcoma	0.000356	0.00247	CbGpPWpGaD
Ketoprofen—Paraesthesia—Doxorubicin—sarcoma	0.000356	0.00063	CcSEcCtD
Ketoprofen—Dyspnoea—Doxorubicin—sarcoma	0.000353	0.000626	CcSEcCtD
Ketoprofen—Feeling abnormal—Epirubicin—sarcoma	0.000353	0.000625	CcSEcCtD
Ketoprofen—Somnolence—Doxorubicin—sarcoma	0.000352	0.000624	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Epirubicin—sarcoma	0.00035	0.00062	CcSEcCtD
Ketoprofen—Dyspepsia—Doxorubicin—sarcoma	0.000349	0.000618	CcSEcCtD
Ketoprofen—CXCL8—GPCR ligand binding—CXCR4—sarcoma	0.000346	0.00239	CbGpPWpGaD
Ketoprofen—Decreased appetite—Doxorubicin—sarcoma	0.000344	0.00061	CcSEcCtD
Ketoprofen—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000342	0.000606	CcSEcCtD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	0.000342	0.00237	CbGpPWpGaD
Ketoprofen—Fatigue—Doxorubicin—sarcoma	0.000342	0.000605	CcSEcCtD
Ketoprofen—Urticaria—Epirubicin—sarcoma	0.00034	0.000602	CcSEcCtD
Ketoprofen—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.00034	0.00235	CbGpPWpGaD
Ketoprofen—Constipation—Doxorubicin—sarcoma	0.000339	0.0006	CcSEcCtD
Ketoprofen—Abdominal pain—Epirubicin—sarcoma	0.000338	0.000599	CcSEcCtD
Ketoprofen—CXCL8—Glucocorticoid receptor regulatory network—TP53—sarcoma	0.000337	0.00234	CbGpPWpGaD
Ketoprofen—CXCL8—Regulation of toll-like receptor signaling pathway—JUN—sarcoma	0.000335	0.00232	CbGpPWpGaD
Ketoprofen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	0.000332	0.0023	CbGpPWpGaD
Ketoprofen—Feeling abnormal—Doxorubicin—sarcoma	0.000326	0.000578	CcSEcCtD
Ketoprofen—Gastrointestinal pain—Doxorubicin—sarcoma	0.000324	0.000574	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—VEGFC—sarcoma	0.000321	0.00222	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—KIT—sarcoma	0.000321	0.00222	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000319	0.00221	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Epirubicin—sarcoma	0.000315	0.000559	CcSEcCtD
Ketoprofen—Urticaria—Doxorubicin—sarcoma	0.000315	0.000557	CcSEcCtD
Ketoprofen—Abdominal pain—Doxorubicin—sarcoma	0.000313	0.000555	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.00031	0.00215	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFC—sarcoma	0.000308	0.00213	CbGpPWpGaD
Ketoprofen—Asthenia—Epirubicin—sarcoma	0.000307	0.000544	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—MYC—sarcoma	0.000307	0.00213	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000307	0.00212	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—JUN—sarcoma	0.000305	0.00211	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—MDM2—sarcoma	0.000305	0.00211	CbGpPWpGaD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000303	0.0021	CbGpPWpGaD
Ketoprofen—Pruritus—Epirubicin—sarcoma	0.000303	0.000536	CcSEcCtD
Ketoprofen—CXCL8—Spinal Cord Injury—EGFR—sarcoma	0.0003	0.00208	CbGpPWpGaD
Ketoprofen—Diarrhoea—Epirubicin—sarcoma	0.000293	0.000519	CcSEcCtD
Ketoprofen—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000292	0.00202	CbGpPWpGaD
Ketoprofen—Hypersensitivity—Doxorubicin—sarcoma	0.000292	0.000517	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000286	0.00198	CbGpPWpGaD
Ketoprofen—Asthenia—Doxorubicin—sarcoma	0.000284	0.000503	CcSEcCtD
Ketoprofen—Dizziness—Epirubicin—sarcoma	0.000283	0.000501	CcSEcCtD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000282	0.00195	CbGpPWpGaD
Ketoprofen—Pruritus—Doxorubicin—sarcoma	0.00028	0.000496	CcSEcCtD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000279	0.00193	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—TP53—sarcoma	0.000277	0.00192	CbGpPWpGaD
Ketoprofen—Vomiting—Epirubicin—sarcoma	0.000272	0.000482	CcSEcCtD
Ketoprofen—Diarrhoea—Doxorubicin—sarcoma	0.000271	0.00048	CcSEcCtD
Ketoprofen—Rash—Epirubicin—sarcoma	0.00027	0.000478	CcSEcCtD
Ketoprofen—Dermatitis—Epirubicin—sarcoma	0.00027	0.000478	CcSEcCtD
Ketoprofen—Headache—Epirubicin—sarcoma	0.000268	0.000475	CcSEcCtD
Ketoprofen—CXCL8—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000267	0.00185	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—JUN—sarcoma	0.000265	0.00184	CbGpPWpGaD
Ketoprofen—CXCL8—Senescence and Autophagy in Cancer—HRAS—sarcoma	0.000265	0.00183	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000264	0.00183	CbGpPWpGaD
Ketoprofen—Dizziness—Doxorubicin—sarcoma	0.000262	0.000464	CcSEcCtD
Ketoprofen—ABCC4—Ectoderm Differentiation—CTNNB1—sarcoma	0.000262	0.00181	CbGpPWpGaD
Ketoprofen—Nausea—Epirubicin—sarcoma	0.000254	0.00045	CcSEcCtD
Ketoprofen—ABCC4—Hemostasis—PLCG1—sarcoma	0.000252	0.00175	CbGpPWpGaD
Ketoprofen—CXCL8—Spinal Cord Injury—TP53—sarcoma	0.000252	0.00175	CbGpPWpGaD
Ketoprofen—Vomiting—Doxorubicin—sarcoma	0.000252	0.000446	CcSEcCtD
Ketoprofen—Rash—Doxorubicin—sarcoma	0.00025	0.000442	CcSEcCtD
Ketoprofen—Dermatitis—Doxorubicin—sarcoma	0.00025	0.000442	CcSEcCtD
Ketoprofen—Headache—Doxorubicin—sarcoma	0.000248	0.00044	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—FLT1—sarcoma	0.000246	0.0017	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PLCG1—sarcoma	0.000242	0.00167	CbGpPWpGaD
Ketoprofen—Nausea—Doxorubicin—sarcoma	0.000235	0.000417	CcSEcCtD
Ketoprofen—CXCR1—Signaling Pathways—CXCR4—sarcoma	0.000232	0.00161	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—MDM2—sarcoma	0.000231	0.0016	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—ATF1—sarcoma	0.00023	0.00159	CbGpPWpGaD
Ketoprofen—PTGS2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000224	0.00155	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—IL2—sarcoma	0.000221	0.00153	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—CCND1—sarcoma	0.00022	0.00152	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000214	0.00148	CbGpPWpGaD
Ketoprofen—ABCC4—Ectoderm Differentiation—MYC—sarcoma	0.000212	0.00147	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—CREB1—sarcoma	0.000211	0.00146	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—JUN—sarcoma	0.0002	0.00139	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TEK—sarcoma	0.000198	0.00137	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—CXCR4—sarcoma	0.000195	0.00135	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—NRAS—sarcoma	0.000189	0.00131	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—IL2—sarcoma	0.000186	0.00129	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—ANGPT2—sarcoma	0.000181	0.00125	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IGF1R—sarcoma	0.00018	0.00125	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CXCR4—sarcoma	0.000177	0.00123	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—MYC—sarcoma	0.000176	0.00122	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—VEGFA—sarcoma	0.000175	0.00121	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular Senescence—TP53—sarcoma	0.000175	0.00121	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—IL2—sarcoma	0.000172	0.00119	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—FOXO1—sarcoma	0.000172	0.00119	CbGpPWpGaD
Ketoprofen—CXCR1—GPCR downstream signaling—IL2—sarcoma	0.000171	0.00119	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PDGFRB—sarcoma	0.000171	0.00119	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—PDGFRA—sarcoma	0.000169	0.00117	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—CCND1—sarcoma	0.000168	0.00116	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TLE1—sarcoma	0.000165	0.00114	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	0.000163	0.00113	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—SRC—sarcoma	0.000162	0.00112	CbGpPWpGaD
Ketoprofen—ALB—Platelet degranulation—VEGFA—sarcoma	0.000161	0.00112	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000158	0.0011	CbGpPWpGaD
Ketoprofen—ABCC4—Platelet activation, signaling and aggregation—VEGFA—sarcoma	0.000158	0.0011	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—IL2—sarcoma	0.000156	0.00108	CbGpPWpGaD
Ketoprofen—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.000154	0.00106	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFC—sarcoma	0.000145	0.00101	CbGpPWpGaD
Ketoprofen—ALB—Folate Metabolism—TP53—sarcoma	0.000142	0.000985	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KDR—sarcoma	0.000142	0.000983	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFC—sarcoma	0.000139	0.000962	CbGpPWpGaD
Ketoprofen—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	0.000139	0.00096	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—MYC—sarcoma	0.000134	0.000931	CbGpPWpGaD
Ketoprofen—CXCL8—Cellular responses to stress—TP53—sarcoma	0.000132	0.000916	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—EGFR—sarcoma	0.000131	0.000911	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000131	0.000906	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KIT—sarcoma	0.000131	0.000905	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—NRAS—sarcoma	0.000131	0.000905	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CREB1—sarcoma	0.000124	0.000862	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—MMP2—sarcoma	0.000121	0.00084	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—EGFR—sarcoma	0.000119	0.000825	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—PLCG1—sarcoma	0.000114	0.00079	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000114	0.00079	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000114	0.000788	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000113	0.000782	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—KRAS—sarcoma	0.000112	0.000779	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—ENO2—sarcoma	0.000112	0.000773	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FLT1—sarcoma	0.000111	0.000769	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—HBA1—sarcoma	0.000111	0.000768	CbGpPWpGaD
Ketoprofen—PTGS2—Spinal Cord Injury—TP53—sarcoma	0.00011	0.000765	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PLCG1—sarcoma	0.000109	0.000756	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CXCR4—sarcoma	0.000105	0.000726	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—ATF1—sarcoma	0.000104	0.000718	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—TLE1—sarcoma	0.000103	0.000713	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MDM2—sarcoma	0.000103	0.000713	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000102	0.000707	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	9.94e-05	0.000688	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—IL2—sarcoma	9.59e-05	0.000664	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling by GPCR—HRAS—sarcoma	9.56e-05	0.000662	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—CREB1—sarcoma	9.51e-05	0.000658	CbGpPWpGaD
Ketoprofen—SLCO1A2—Metabolism—PLCG1—sarcoma	9.47e-05	0.000656	CbGpPWpGaD
Ketoprofen—CXCL8—Metabolism of proteins—CTNNB1—sarcoma	9.3e-05	0.000644	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NPM1—sarcoma	9.29e-05	0.000643	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—IL2—sarcoma	9.2e-05	0.000637	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	9.14e-05	0.000633	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CCND1—sarcoma	8.97e-05	0.000621	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—JUN—sarcoma	8.95e-05	0.00062	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	8.94e-05	0.000619	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—CTNNB1—sarcoma	8.88e-05	0.000615	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—ENO2—sarcoma	8.49e-05	0.000588	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	8.45e-05	0.000585	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—HBA1—sarcoma	8.43e-05	0.000584	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—IL2—sarcoma	8.42e-05	0.000583	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—SRC—sarcoma	8.37e-05	0.00058	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—VEGFA—sarcoma	8.15e-05	0.000564	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IGF1R—sarcoma	8.13e-05	0.000563	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—NRAS—sarcoma	8.05e-05	0.000558	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—ENO2—sarcoma	8.04e-05	0.000557	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—SRC—sarcoma	8.03e-05	0.000556	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—VEGFA—sarcoma	7.82e-05	0.000541	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—FOXO1—sarcoma	7.74e-05	0.000536	CbGpPWpGaD
Ketoprofen—CXCL8—GPCR downstream signaling—IL2—sarcoma	7.74e-05	0.000536	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PDGFRB—sarcoma	7.73e-05	0.000535	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—NRAS—sarcoma	7.72e-05	0.000535	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—PDGFRA—sarcoma	7.61e-05	0.000527	CbGpPWpGaD
Ketoprofen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	7.51e-05	0.00052	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—SRC—sarcoma	7.35e-05	0.000509	CbGpPWpGaD
Ketoprofen—PTGS1—Metabolism—PLCG1—sarcoma	7.2e-05	0.000499	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—MYC—sarcoma	7.19e-05	0.000498	CbGpPWpGaD
Ketoprofen—ALB—Platelet activation, signaling and aggregation—VEGFA—sarcoma	7.15e-05	0.000496	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—EGFR—sarcoma	7.03e-05	0.000487	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—IL2—sarcoma	7.03e-05	0.000487	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—KRAS—sarcoma	6.93e-05	0.00048	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PLCG1—sarcoma	6.83e-05	0.000473	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—ENO2—sarcoma	6.74e-05	0.000467	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—HBA1—sarcoma	6.69e-05	0.000464	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—KRAS—sarcoma	6.65e-05	0.00046	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CXCR4—sarcoma	6.56e-05	0.000454	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KDR—sarcoma	6.4e-05	0.000443	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—TP53—sarcoma	6.16e-05	0.000427	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—TP53—sarcoma	5.91e-05	0.000409	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KIT—sarcoma	5.9e-05	0.000409	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—NRAS—sarcoma	5.9e-05	0.000409	CbGpPWpGaD
Ketoprofen—ABCC4—Hemostasis—HRAS—sarcoma	5.89e-05	0.000408	CbGpPWpGaD
Ketoprofen—PTGS2—Metabolism—PLCG1—sarcoma	5.72e-05	0.000396	CbGpPWpGaD
Ketoprofen—CXCR1—Signaling Pathways—HRAS—sarcoma	5.65e-05	0.000391	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CREB1—sarcoma	5.62e-05	0.000389	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—ENO2—sarcoma	5.48e-05	0.00038	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—ENO2—sarcoma	5.45e-05	0.000377	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—HBA1—sarcoma	5.45e-05	0.000377	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—HBA1—sarcoma	5.42e-05	0.000375	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—EGFR—sarcoma	5.37e-05	0.000372	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—KRAS—sarcoma	5.08e-05	0.000352	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—FOXO1—sarcoma	4.84e-05	0.000335	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PDGFRB—sarcoma	4.83e-05	0.000335	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—PDGFRA—sarcoma	4.76e-05	0.00033	CbGpPWpGaD
Ketoprofen—CYP2C8—Metabolism—PLCG1—sarcoma	4.65e-05	0.000322	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MDM2—sarcoma	4.65e-05	0.000322	CbGpPWpGaD
Ketoprofen—ALB—Metabolism—PLCG1—sarcoma	4.62e-05	0.00032	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—ENO2—sarcoma	4.46e-05	0.000309	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—HBA1—sarcoma	4.43e-05	0.000307	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—IL2—sarcoma	4.34e-05	0.000301	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling by GPCR—HRAS—sarcoma	4.32e-05	0.000299	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—IL2—sarcoma	4.15e-05	0.000287	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CCND1—sarcoma	4.05e-05	0.00028	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—JUN—sarcoma	4.04e-05	0.00028	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—CTNNB1—sarcoma	4.01e-05	0.000278	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—SRC—sarcoma	3.79e-05	0.000262	CbGpPWpGaD
Ketoprofen—CYP2C9—Metabolism—PLCG1—sarcoma	3.79e-05	0.000262	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KIT—sarcoma	3.69e-05	0.000256	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—VEGFA—sarcoma	3.69e-05	0.000255	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—NRAS—sarcoma	3.64e-05	0.000252	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—SRC—sarcoma	3.62e-05	0.000251	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—VEGFA—sarcoma	3.53e-05	0.000244	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CREB1—sarcoma	3.51e-05	0.000243	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—NRAS—sarcoma	3.48e-05	0.000241	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—MYC—sarcoma	3.25e-05	0.000225	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—EGFR—sarcoma	3.17e-05	0.00022	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—KRAS—sarcoma	3.14e-05	0.000217	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—KRAS—sarcoma	3e-05	0.000208	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MDM2—sarcoma	2.91e-05	0.000201	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—TP53—sarcoma	2.79e-05	0.000193	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—TP53—sarcoma	2.67e-05	0.000185	CbGpPWpGaD
Ketoprofen—ALB—Hemostasis—HRAS—sarcoma	2.67e-05	0.000185	CbGpPWpGaD
Ketoprofen—CXCL8—Signaling Pathways—HRAS—sarcoma	2.55e-05	0.000177	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—CTNNB1—sarcoma	2.51e-05	0.000174	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—SRC—sarcoma	2.27e-05	0.000157	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—NRAS—sarcoma	2.18e-05	0.000151	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—MYC—sarcoma	2.03e-05	0.000141	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—EGFR—sarcoma	1.99e-05	0.000138	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—KRAS—sarcoma	1.88e-05	0.00013	CbGpPWpGaD
Ketoprofen—PTGS2—Disease—HRAS—sarcoma	1.59e-05	0.00011	CbGpPWpGaD
